AIFA - Allergy and Immunology Foundation of Australasia
AIFA has awarded more than $629,000 in research grants to 27 pojects since the program commenced in 2015. This includes:
- $115,000 to be awarded to 4 research projects in 2022, to be announced at the ASCIA 2022 Hybrid Conference AIFA Symposium, that will feature presentations from past AIFA grant recipients 2020.
- $127,000 awarded to 5 research projects in 2021. These were announced at the ASCIA 2021 Virtual Conference AIFA Symposium, that featured presentations from past AIFA grant recipients 2015-2019.
- $110,000 awarded to 5 research projects in 2020.
- $120,000 awarded to 5 research projects in 2019.
All research projects that have been awarded AIFA grants are listed on the AIFA website www.allergyimmunology.org.au/projects
AIFA grant rounds open in March and are announced at the ASCIA conference in September. Expression of interest (EOI) forms will be on the AIFA website www.allergyimmunology.org.au/grants
To be eligible for an AIFA grant the Chief Investigator must be an ASCIA member and the research needs to be carried out by the chief investigator and designated team in a non-profit institution in Australia or New Zealand.
Thank you to the AIFA expert grant selection panel, led by Dr Melanie Wong, who volunteer their time to work on a robust selection process.
Thank you also to our generous AIFA donors and sponsors:
- All donations of $100 or more are perpetually acknowledged on the AIFA website www.allergyimmunology.org.au/our-supporters/donors
- Significant donors (of $10,000 or more) may request targeted research project funding in particular areas.
By donating to AIFA or sponsoring an AIFA grant, you can be reassured that 100% of donations and sponsorship to AIFA directly fund allergy/immunology research grants.
There are many projects with great potential that still require funding, so we seek your support for future AIFA grants.
AIFA research grants encourage:
- Emerging researchers who may not yet receive grants from the NHMRC or other organisations.
- Innovative research that requires seed funding.
- Collaborative research projects conducted throughout Australia and New Zealand.
- Projects that will translate to better treatment and care for patients with allergy and other immune diseases.
AIFA was established in 2013 by ASCIA, the peak professional body for allergy and clinical immunology in Australasia. The aim of AIFA is to improve the health and care of people with allergy and other immune diseases by funding medical research in Australia and New Zealand.
Allergy and other immune system disorders (primary immunodeficiencies and autoimmune diseases) are amongst the most important chronic diseases and public health issues in Australia and New Zealand, affecting around 25% of the population. Funding of research into allergy and other immune diseases is vital for the prevention and treatment of these diseases, and to ultimately find cures.
Content updated August 2022